ChatGPT builds a $1,000 stock portfolio for 2026, highlighting Microsoft, Nvidia, energy and defence stocks positioned for AI growth and market uncertainty.

The magazine’s most-read articles of the year included a deep dive on the Scopes "monkey trial," an interview with ...

Tradipitant is a neurokinin-1 receptor antagonist licensed by Vanda from Eli Lilly and Company. ・The drug is also being ...

ABL Bio (CEO Sang Hoon Lee), a company specializing in bispecific antibodies, announced that ABL Bio will receive a USD 40 million upfront payment for the license, research and collaboration agreement ...

U.S. regulators on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity. The U.S. Food and Drug Administration’s ...

But Eli Lilly's Zepbound is best in class. Zepbound caused greater average weight loss than Wegovy in a head-to-head study. And through the first nine months of 2025, Zepbound generated $9.3 billion ...

Asian shares are mixed in thin holiday trading, with most markets in the region and elsewhere closed for Christmas ...

The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.

NEW YORK — Wall Street slightly higher in midday trading Wednesday as markets hovered near record levels on a ...

Novo Nordisk A/S is rated a Buy with improved execution and valuation gap with LLY to drive outperformance through 2026. Read ...

Eli Lilly hiked its revenue growth guidance by 7%, while Novo Nordisk was forced to slash its targets by ~12%. See why I'm still bullish on LLY stock.

Three inmates, all accused of violent crimes, are back in custody after escaping from an Atlanta-area jail. It’s still unclear exactly how they got out, but police say their recorded jailhouse phone ...